CN Patent

CN110156624B — 一种米诺环素及其衍生物的合成方法

Assigned to Hebei Jiheng (Group) Pharmaceutical Co.,Ltd. · Expires 2022-03-08 · 4y expired

What this patent protects

本发明涉及一种米诺环素与取代米诺环素的合成方法，特别是9‑氨基米诺环素的合成。9‑氨基米诺环素是替加环素的重要中简体，替加环素被用于多重耐药菌的控制。本发明的原料易得，合成路线短，反应条件温和，收率高，工艺简单，适合规模化生产。

USPTO Abstract

本发明涉及一种米诺环素与取代米诺环素的合成方法，特别是9‑氨基米诺环素的合成。9‑氨基米诺环素是替加环素的重要中简体，替加环素被用于多重耐药菌的控制。本发明的原料易得，合成路线短，反应条件温和，收率高，工艺简单，适合规模化生产。

Drugs covered by this patent

sarecycline-hydrochloride (SARECYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN110156624B
Jurisdiction: CN
Classification: —
Expires: 2022-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Hebei Jiheng (Group) Pharmaceutical Co.,Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.